Fate Therapeutics
FATE
#8959
Rank
C$0.21 B
Marketcap
C$1.85
Share price
4.65%
Change (1 day)
19.27%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: C$0.21 Billion

As of April 2026 Fate Therapeutics has a market cap of C$0.21 Billion. This makes Fate Therapeutics the world's 8959th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.21 B36.26%
2025C$0.15 B-39.96%
2024C$0.26 B-46.2%
2023C$0.48 B-63.24%
2022C$1.33 B-81.32%
2021C$7.12 B-29.6%
2020C$10.11 B422.58%
2019C$1.93 B71.2%
2018C$1.13 B179.61%
2017C$0.40 B189.66%
2016C$0.13 B3.99%
2015C$0.13 B11.81%
2014C$0.12 B-12.1%
2013C$0.13 B

End of Day market cap according to different sources

On Apr 15th, 2026 the market cap of Fate Therapeutics was reported to be:

C$0.20 Billion
by Nasdaq info icon info icon
C$0.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
C$76.62 B 35,496.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.05 B 1,317.43%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$8.18 B 3,701.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$17.87 B 8,206.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$15.42 B 7,067.09%๐Ÿ‡บ๐Ÿ‡ธ USA